Setting a new standard In Animal Health
Harnessing the power of stem cell therapy to treat the root cause of disease
Delivering the Future of Veterinary Medicine
Pets with inflammatory and immune-mediated diseases often have few or no treatment options. They may have pain, limited mobility, and even a shorter lifespan because we can only treat the symptoms, not the cause.
At Gallant, we’re pioneering stem cell therapies that have the potential to transform the treatment of pet diseases.
Addressing the Root Cause
Stem cells have been shown to reduce inflammation, decrease scarring, increase blood supply, and regenerate healthy tissue. Our mesenchymal stem cells (MSCs) target the root cause of diseases, using natural biological mechanisms to help restore pets’ bodies.
Learn more about our off-the-shelf stem cell platform.
Developing Our Product Pipeline
We’re leading the introduction of a new class of therapies that could have a marked impact on the lives of pets and their parents across a broad range of diseases.
Explore our clinical trials pipeline to learn more.
Trailblazing a New Future
We’re leaders in veterinary regenerative medicine, with deep industry experience in cell therapy development and a love of and commitment to animals.
As part of this commitment, we're working toward a new treatment for feline chronic gingivostomatitis (FCGS), a painful and persistent oral condition in cats.
Gallant in the News
Get the latest news about how we're shaping the future of animal health